Autophagy modulation as a target for anticancer drug discovery

68Citations
Citations of this article
90Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Autophagy, an evolutionarily conserved catabolic process involving the engulfment and degradation of non-essential or abnormal cellular organelles and proteins, is crucial for homeostatic maintenance in living cells. This highly regulated, multi-step process has been implicated in diverse diseases including cancer. Autophagy can function as either a promoter or a suppressor of cancer, which makes it a promising and challenging therapeutic target. Herein, we overview the regulatory mechanisms and dual roles of autophagy in cancer. We also describe some of the representative agents that exert their anticancer effects by regulating autophagy. Additionally, some emerging strategies aimed at modulating autophagy are discussed as having the potential for future anticancer drug discovery. In summary, these findings will provide valuable information to better utilize autophagy in the future development of anticancer therapeutics that meet clinical requirements. © 2013 CPS and SIMM All rights reserved.

Cite

CITATION STYLE

APA

Li, X., Xu, H. L., Liu, Y. X., An, N., Zhao, S., & Bao, J. K. (2013, May). Autophagy modulation as a target for anticancer drug discovery. Acta Pharmacologica Sinica. https://doi.org/10.1038/aps.2013.23

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free